Cannlabs Stock Price To Earning
| CANL Stock | USD 0.0001 0.00 0.00% |
Cannlabs fundamentals help investors to digest information that contributes to Cannlabs' financial success or failures. It also enables traders to predict the movement of Cannlabs Pink Sheet. The fundamental analysis module provides a way to measure Cannlabs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannlabs pink sheet.
Cannlabs |
Cannlabs Company Price To Earning Analysis
Cannlabs' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Cannlabs Price To Earning | (4.81) X |
Most of Cannlabs' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannlabs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Cannlabs has a Price To Earning of -4.81 times. This is 118.61% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The price to earning for all United States stocks is 116.75% higher than that of the company.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Cannlabs Fundamentals
| Return On Asset | -3.62 | |||
| Profit Margin | (0.96) % | |||
| Operating Margin | (2.50) % | |||
| Current Valuation | 14.91 M | |||
| Shares Outstanding | 62.63 M | |||
| Price To Earning | (4.81) X | |||
| Price To Book | 25.41 X | |||
| Price To Sales | 6.91 X | |||
| Revenue | 1.36 M | |||
| Gross Profit | 478.11 K | |||
| EBITDA | (3.99 M) | |||
| Net Income | (1.58 M) | |||
| Cash And Equivalents | 17.59 K | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.26 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 37 | |||
| Beta | 1.56 | |||
| Market Capitalization | 14.76 M | |||
| Total Asset | 1.32 M | |||
| Retained Earnings | (1.64 M) | |||
| Working Capital | (1.53 M) | |||
| Current Asset | 145 K | |||
| Current Liabilities | 1.68 M | |||
| Z Score | -11.5 | |||
| Net Asset | 1.32 M |
About Cannlabs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannlabs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannlabs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannlabs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cannlabs Pink Sheet
Cannlabs financial ratios help investors to determine whether Cannlabs Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannlabs with respect to the benefits of owning Cannlabs security.